Farnesoid X receptor (FXR) activation and FXR genetic variation in inflammatory bowel disease

Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes

Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038 · see citing works

Haploview: analysis and visualization of LD and haplotype maps

Barrett, J., Fry, B., Maller, J., & Daly, M. (2005) · Bioinform. · doi:10.1093/bioinformatics/bth457 · Cited by 15,086 · see citing works

The nuclear receptor superfamily: the second decade

Mangelsdorf, D. J., Thummel, C., Beato, M., Herrlich, P., Schütz, G., Umesono, K., Blumberg, B., Kastner, P., Mark, M., Chambon, P., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90199-x · Cited by 6,964 · see citing works

Toward an Integrated Clinical, Molecular and Serological Classification of Inflammatory Bowel Disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology

Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J., Gasché, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,408 · see citing works

Inflammatory Bowel Disease

Podolsky, D. K. (2002) · New England Journal of Medicine · doi:10.1056/nejmra020831 · Cited by 3,183 · see citing works

Inflammatory bowel disease

Abraham, C., & Cho, J. H. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804647 · Cited by 2,712 · see citing works

Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci

Franke, A., McGovern, D. P. B., Barrett, J. C., Wang, K., Radford-Smith, G. L., Ahmad, T., Lees, C. W., Balschun, T., Lee, J., Roberts, R., et al. (2010) · Nature Genetics · doi:10.1038/ng.717 · Cited by 2,520 · see citing works

Nuclear Receptors and Lipid Physiology: Opening the X-Files

Chawla, A., Repa, J. J., Evans, R. M., & Mangelsdorf, D. J. (2001) · Science · doi:10.1126/science.294.5548.1866 · Cited by 2,085 · see citing works

Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis

Sartor, R. B. (2006) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep0528 · Cited by 1,763 · see citing works

Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47

Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D’Amato, M., Taylor, K. D., Lee, J. C., Goyette, P., Imielinski, M. B., Latiano, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.764 · Cited by 1,312 · see citing works

Regulation of antibacterial defense in the small intestine by the nuclear bile acid receptor

Inagaki, T., Moschetta, A., Lee, Y.-K., Peng, L., Zhao, G., Downes, M., Yu, R. T., Shelton, J. M., Richardson, J. A., Repa, J. J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509592103 · Cited by 1,164 · see citing works

Farnesoid X receptor activation inhibits inflammation and preserves the intestinal barrier in inflammatory bowel disease

Gadaleta, R. M., van Erpecum, K. J., Oldenburg, B., Willemsen, E. C. L., Renooij, W., Murzilli, S., Klomp, L. W. J., Siersema, P. D., Schipper, M. E. I., Danese, S., et al. (2011) · Gut · doi:10.1136/gut.2010.212159 · Cited by 870 · cited 4× · see citing works

Analysing biological pathways in genome-wide association studies

Wang, K., Li, M., & Hakonarson, H. H. (2010) · Nature Reviews Genetics · doi:10.1038/nrg2884 · Cited by 757 · see citing works

Nuclear factor κB is activated in macrophages and epithelial cells of inflamed intestinal mucosa

Rogler, G., Brand, K., Vogl, D., Page, S., Hofmeister, R., Andus, T., Knuechel, R., Baeuerle, P. A., Schölmerich, J., & Groß, V. (1998) · Gastroenterology · doi:10.1016/s0016-5085(98)70202-1 · Cited by 715 · see citing works

The bile acid receptor FXR is a modulator of intestinal innate immunity

Vavassori, P., Mencarelli, A., Renga, B., Distrutti, E., & Fiorucci, S. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803978 · Cited by 655 · see citing works

Farnesoid X receptor antagonizes nuclear factor κB in hepatic inflammatory response

Wang, Y.-D., Chen, W.-D., Wang, M., Yu, D., Forman, B. M., & Huang, W. (2008) · Hepatology · doi:10.1002/hep.22519 · Cited by 639 · cited 2× · see citing works

FXR: a metabolic regulator and cell protector

Wang, Y.-D., Chen, W.-D., Moore, D. D., & Huang, W. (2008) · Cell Research · doi:10.1038/cr.2008.289 · Cited by 389 · see citing works

Functional Variants of the Central Bile Acid Sensor FXR Identified in Intrahepatic Cholestasis of Pregnancy

van Mil, S. W. C., Milona, A., Dixon, P. H., Müllenbach, R., Geenes, V. L., Chambers, J., Shevchuk, V., Moore, G. E., Lammert, F., Glantz, A., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.05.015 · Cited by 257 · see citing works

Activation of bile salt nuclear receptor FXR is repressed by pro-inflammatory cytokines activating NF-κB signaling in the intestine

Gadaleta, R. M., Oldenburg, B., Willemsen, E. C. L., Spit, M., Murzilli, S., Salvatore, L., Klomp, L. W. J., Siersema, P. D., van Erpecum, K. J., & van Mil, S. W. C. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.04.005 · Cited by 195 · see citing works

Human ileal bile acid transporter gene ASBT ( SLC10A2 ) is transactivated by the glucocorticoid receptor

Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gut · doi:10.1136/gut.53.1.78 · Cited by 188 · see citing works

Molecular prediction of disease risk and severity in a large Dutch Crohn’s disease cohort

Weersma, R. K., Stokkers, P. C. F., Bodegraven, A. A. V., van Hogezand, R. A., Verspaget, H. W., de Jong, D. J., van der Woude, C. J., Oldenburg, B., Linskens, R. K., Festen, E. A. M., et al. (2008) · Gut · doi:10.1136/gut.2007.144865 · Cited by 182 · see citing works

Human ileal bile acid transporter gene ASBT (SLC10A2) is transactivated by the glucocorticoid receptor

Jung, D., Fantin, A. C., Scheurer, U., Fried, M., & Kullak-Ublick, G. A. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)80515-2 · Cited by 170 · see citing works

Defensins and other antimicrobial peptides in inflammatory bowel disease

Wehkamp, J., Schmid, M., & Stange, E. F. (2007) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e328136c580 · Cited by 167 · see citing works

Associations with tight junction genes PARD3 and MAGI2 in Dutch patients point to a common barrier defect for coeliac disease and ulcerative colitisAn unusual case of ascites

Wapenaar, M. C., Monsuur, A. J., Bodegraven, A. A. V., Weersma, R., Bevova, M. R., Linskens, R. K., Howdle, P. D., Holmes, G. K. T., Mulder, C. J. J., Dijkstra, G. D. H., et al. (2007) · Gut · doi:10.1136/gut.2007.133132 · Cited by 163 · see citing works

Polymorphisms in E-cadherin ( CDH1 ) result in a mis-localised cytoplasmic protein that is associated with Crohn’s disease

Muise, A. M., Walters, T. D., Glowacka, W. K., Griffiths, A. M., Ngan, B., Lan, H., Xu, W., Silverberg, M. S., & Rotin, D. (2009) · Gut · doi:10.1136/gut.2008.175117 · Cited by 153 · see citing works

Genetic Variation in Myosin IXB Is Associated With Ulcerative Colitis

Bodegraven, A. A. V., Curley, C., Hunt, K. A., Monsuur, A. J., Linskens, R. K., Onnie, C. M., Crusius, J. B. A., Annese, V., Latiano, A., Silverberg, M. S., et al. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.09.011 · Cited by 119 · see citing works

Protein Microarray Analysis of Disease Activity in Pediatric Inflammatory Bowel Disease Demonstrates Elevated Serum PLGF, IL-7, TGF-beta1, and IL-12p40 Levels in Crohn's Disease and Ulcerative Colitis Patients in Remission versus Active Disease

Kader, H. A., Tchernev, V. T., Satyaraj, E., Lejnine, S., Kotler, G., Kingsmore, S. F., & Patel, D. D. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.40819.x · Cited by 112 · see citing works

Diagnostic misclassification reduces the ability to detect linkage in inflammatory bowel disease genetic studies

Silverberg, M. S., Daly, M. J., Moskovitz, D. N., Rioux, J. D., McLeod, R. S., Cohen, Z., Greenberg, G. R., Hudson, T., Siminovitch, K. A., & Steinhart, A. H. (2001) · Gut · doi:10.1136/gut.49.6.773 · Cited by 57 · see citing works

MAGI2 genetic variation and inflammatory bowel disease

McGovern, D. P. B., Taylor, K. D., Landers, C. J., Derkowski, C. A., Dutridge, D., Dubinsky, M. C., Ippoliti, A., Vasiliauskas, E., Mei, L., Mengesha, E., et al. (2008) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20611 · Cited by 56 · see citing works

Altered Fecal Bile Acid Pattern in Patients with Inflammatory Bowel Disease

Kruis, W., Kalek, H.-D., Stellaard, F., & Paumgartner, G. (2009) · Digestion · doi:10.1159/000199367 · Cited by 55 · see citing works

Protein-Tyrosine Phosphatase Sigma Is Associated with Ulcerative Colitis

Muise, A. M., Walters, T. D., Wine, E., Griffiths, A. M., Turner, D., Duerr, R. H., Regueiro, M. D., Ngan, B., Xu, W., Sherman, P. M., et al. (2007) · Current Biology · doi:10.1016/j.cub.2007.06.013 · Cited by 55 · see citing works

Bile acid studies in patients with Crohn's colitis.

Rutgeerts, P., Ghoos, Y. F., & Vantrappen, G. (1979) · Gut · doi:10.1136/gut.20.12.1072 · Cited by 40 · see citing works

Faecal bile acid excretion in children with inflammatory bowel disease.

Ejderhamn, J., Rafter, J. J., & Strandvik, B. (1991) · Gut · doi:10.1136/gut.32.11.1346 · Cited by 37 · see citing works

Bile Acid Metabolism in Patients with Crohn's Disease in Terminal Ileum

Tougaard, L., Giese, B., Pedersen, B. H., & Binder, V. (1986) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365528609003110 · Cited by 27 · see citing works

Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis

Jia, W., Xie, G., & Jia, W. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.119 · Cited by 1,924 · see citing works

Commensal bacteria at the interface of host metabolism and the immune system

Brestoff, J. R., & Artis, D. (2013) · Nature Immunology · doi:10.1038/ni.2640 · Cited by 945 · see citing works

Bile acid signaling in metabolic disease and drug therapy

Li, T., & Chiang, J. Y. L. (2014) · Pharmacological Reviews · doi:10.1124/pr.113.008201 · Cited by 935 · see citing works

Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System

Postler, T. S., & Ghosh, S. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.05.008 · Cited by 876 · see citing works

Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets

Fleishman, J. S., & Kumar, S. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01811-6 · Cited by 577 · see citing works

Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology

Fuchs, C. D., & Trauner, M. (2022) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00566-7 · Cited by 490 · see citing works

Molecular physiology of bile acid signaling in health, disease, and aging

Perino, A., Demagny, H., Velazquez-Villegas, L., & Schoonjans, K. (2021) · Physiological Reviews · doi:10.1152/physrev.00049.2019 · Cited by 481 · see citing works

Emerging roles of bile acids in mucosal immunity and inflammation

Chen, M. L., Takeda, K., & Sundrud, M. S. (2019) · Mucosal Immunology · doi:10.1038/s41385-019-0162-4 · Cited by 301 · see citing works

Guts and Gall: Bile Acids in Regulation of Intestinal Epithelial Function in Health and Disease

Hegyi, P., Maléth, J., Walters, J. R., Hofmann, A. F., & Keely, S. J. (2018) · Physiological Reviews · doi:10.1152/physrev.00054.2017 · Cited by 269 · see citing works

Bile Acid Signaling in Inflammatory Bowel Diseases

Fiorucci, S., Carino, A., Baldoni, M., Santucci, L., Costanzi, E., Graziosi, L., Distrutti, E., & Biagioli, M. (2020) · Digestive Diseases and Sciences · doi:10.1007/s10620-020-06715-3 · Cited by 231 · see citing works

Pregnane X receptor as a target for treatment of inflammatory bowel disorders

Cheng, J., Shah, Y. M., & Gonzalez, F. J. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.03.003 · Cited by 159 · see citing works

Impact of Microbial Metabolites on Microbiota–Gut–Brain Axis in Inflammatory Bowel Disease

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041623 · Cited by 159 · see citing works

Bacterial Bile Metabolising Gene Abundance in Crohn's, Ulcerative Colitis and Type 2 Diabetes Metagenomes

Labbé, A., Ganopolsky, J. G., Martoni, C., Prakash, S., & Jones, M. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115175 · Cited by 144 · see citing works

The gut microbiota as a therapeutic target in IBD and metabolic disease: a role for the bile acid receptors FXR and TGR5

Baars, A., Oosting, A., Knol, J., Garssen, J., & Van Bergenhenegouwen, J. (2015) · Microorganisms · doi:10.3390/microorganisms3040641 · Cited by 135 · see citing works

Natural products as modulators of the nuclear receptors and metabolic sensors LXR, FXR and RXR

Hiebl, V., Ladurner, A., Latkolik, S. L., & Dirsch, V. M. (2018) · Biotechnology Advances · doi:10.1016/j.biotechadv.2018.03.003 · Cited by 135 · see citing works

Systematic review: bile acids and intestinal inflammation‐luminal aggressors or regulators of mucosal defence?

Pavlidis, P., Powell, N., Vincent, R. P., Ehrlich, S. D., Bjarnason, I., & Hayee, B. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13333 · Cited by 132 · see citing works

Fibroblast Growth Factor 19 modulates intestinal microbiota and inflammation in presence of Farnesoid X Receptor

Gadaleta, R. M., García‐Irigoyen, O., Cariello, M., Scialpi, N., Peres, C., Vetrano, S., Fiorino, G., Danese, S., Ko, B., Luo, J., et al. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2020.102719 · Cited by 125 · see citing works

Bile acids and their receptors in regulation of gut health and diseases

Lin, S., Wang, S., Wang, P., Tang, C., Wang, Z., Chen, L., Luo, G., Chen, H., Liu, Y., Feng, B., et al. (2022) · Progress in Lipid Research · doi:10.1016/j.plipres.2022.101210 · Cited by 123 · see citing works

Microbial Metabolites, Postbiotics, and Intestinal Epithelial Function

Mayorgas, A., Dotti, I., & Salas, A. (2020) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202000188 · Cited by 118 · see citing works

Microbiota regulate intestinal epithelial gene expression by suppressing the transcription factor Hepatocyte nuclear factor 4 alphaPreprint

Davison, J. M., Lickwar, C. R., Song, L., Breton, G., Crawford, G. E., & Rawls, J. F. (2017) · Genome Research · doi:10.1101/gr.220111.116 · Cited by 111 · see citing works

Tissue-specific actions of FXR in metabolism and cancer

Gadaleta, R. M., Cariello, M., Sabbà, C., & Moschetta, A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.005 · Cited by 110 · see citing works

The Bile Acid Sensor FXR Is Required for Immune-Regulatory Activities of TLR-9 in Intestinal Inflammation

Renga, B., Mencarelli, A., Cipriani, S., D’Amore, C., Carino, A., Bruno, A. M., Francisci, D., Zampella, A., Distrutti, E., & Fiorucci, S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054472 · Cited by 106 · see citing works

Bile acids activated receptors in inflammatory bowel disease

Biagioli, M., Marchianò, S., Carino, A., Di Giorgio, C., Santucci, L., Distrutti, E., & Fiorucci, S. (2021) · Cells · doi:10.3390/cells10061281 · Cited by 103 · see citing works

Bile Acid Malabsorption in Inflammatory Bowel Disease

Vı́tek, L. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000193 · Cited by 101 · see citing works

Bile acids: From digestion to cancers

Baptissart, M., Vega, A., Maqdasy, S., Caira, F., Baron, S., Lobaccaro, J.-M. A., & Volle, D. H. (2013) · Biochimie · doi:10.1016/j.biochi.2012.06.022 · Cited by 97 · see citing works

Nuclear receptor FXR, bile acids and liver damage: Introducing the progressive familial intrahepatic cholestasis with FXR mutations

Cariello, M., Piccinin, E., García‐Irigoyen, O., Sabbà, C., & Moschetta, A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.09.019 · Cited by 97 · see citing works

Trimethylamine-N-oxide: A Novel Biomarker for the Identification of Inflammatory Bowel Disease

Wilson, A. S., Teft, W. A., Morse, B. L., Choi, Y., Woolsey, S., DeGorter, M. K., Hegele, R. A., Tirona, R. G., & Kim, R. B. (2015) · Digestive Diseases and Sciences · doi:10.1007/s10620-015-3797-3 · Cited by 97 · see citing works

FXR and liver carcinogenesis

Huang, X., Zhao, W., & Huang, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.117 · Cited by 95 · see citing works

A pilot study of fecal bile acid and microbiota profiles in inflammatory bowel disease and primary sclerosing cholangitis

Vaughn, B. P., Kaiser, T., Staley, C. M., Hamilton, M. J., Reich, J., Graiziger, C. T., Singroy, S., Kabage, A. J., Sadowsky, M. J., & Khoruts, A. (2019) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s186097 · Cited by 92 · see citing works

Inflammatory Bowel Disease Alters Intestinal Bile Acid Transporter Expression

Jahnel, J., Fickert, P., Hauer, A. C., Högenauer, C., Avian, A., & Trauner, M. (2014) · Drug Metabolism and Disposition · doi:10.1124/dmd.114.058065 · Cited by 92 · see citing works

Western Diet Deregulates Bile Acid Homeostasis, Cell Proliferation, and Tumorigenesis in Colon

Đermadi, D., Valo, S., Ollila, S., Soliymani, R., Sipari, N., Pussila, M., Sarantaus, L., Lindén, J., Baumann, M., & Nyström, M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2860 · Cited by 89 · see citing works

Immunology of bile acids regulated receptors

Fiorucci, S., Marchianò, S., Urbani, G., Giorgio, C. D., Distrutti, E., Zampella, A., & Biagioli, M. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101291 · Cited by 84 · see citing works

The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity

Anderson, K. M., & Gayer, C. P. (2021) · Cells · doi:10.3390/cells10113206 · Cited by 82 · see citing works

The Impact of Farnesoid X Receptor Activation on Intestinal Permeability in Inflammatory Bowel Disease

Stojančević, M., Stankov, K., & Mikov, M. (2012) · Canadian Journal of Gastroenterology · doi:10.1155/2012/538452 · Cited by 77 · see citing works

Attenuation of bile acid-mediated FXR and PXR activation in patients with Crohn’s disease

Wilson, A. S., Almousa, A. A., Teft, W. A., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-58644-w · Cited by 75 · see citing works

Role of bile acids in inflammatory bowel disease

Tiratterra, E. (2018) · Annals of Gastroenterology · doi:10.20524/aog.2018.0239 · Cited by 72 · see citing works

FXR mediates ILC-intrinsic responses to intestinal inflammation

Fu, T., Li, Y., Oh, T. G., Cayabyab, F., He, N., Tang, Q., Coulter, S., Truitt, M., Medina, P., He, M., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2213041119 · Cited by 67 · see citing works

Nuclear Receptors Regulate Intestinal Inflammation in the Context of IBD

Klepsch, V., Moschen, A. R., Tilg, H., Baier, G., & Hermann‐Kleiter, N. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01070 · Cited by 63 · see citing works

The gut-liver axis

Visschers, R. G. J., Luyer, M. D., Schaap, F. G., Olde Damink, S. W. M., & Soeters, P. B. (2013) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32836410a4 · Cited by 60 · see citing works

The Complex Relationship Between Microbiota, Immune Response and Creeping Fat in Crohn’s Disease

Suau, R., Pardina, E., Domènech, E., Lorén, V., & Manyé, J. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab159 · Cited by 59 · see citing works

Association of genetic variation in the NR1H4 gene, encoding the nuclear bile acid receptor FXR, with inflammatory bowel disease

Attinkara, R., Mwinyi, J., Truninger, K., Reguła, J., Gaj, P., Rogler, G., Kullak-Ublick, G. A., Eloranta, J. J., & The Swiss IBD Cohort Study Group (2012) · BMC Research Notes · doi:10.1186/1756-0500-5-461 · Cited by 56 · see citing works

Extending the Structure–Activity Relationship of Anthranilic Acid Derivatives As Farnesoid X Receptor Modulators: Development of a Highly Potent Partial Farnesoid X Receptor Agonist

Merk, D., Lamers, C., Ahmad, K. A., Gomez, R. C., Schneider, G., Steinhilber, D., & Schubert‐Zsilavecz, M. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500937v · Cited by 55 · see citing works

Farnesoid X Receptor Expression Is Decreased in Colonic Mucosa of Patients with Primary Sclerosing Cholangitis and Colitis-associated Neoplasia

Torres, J., Bao, X., Iuga, A. C., Chen, A., Harpaz, N., Ullman, T. A., Cohen, B. L., de Chambrun, G. P., Asciutti, S., Odin, J. A., et al. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318286ff2e · Cited by 54 · see citing works

Farnesoid X receptor mediates macrophage-intrinsic responses to suppress colitis-induced colon cancer progression

Dong, X., Qi, M., Cai, C., Zhu, Y., Li, Y., Coulter, S., Sun, F., Liddle, C., Uboha, N. V., Halberg, R. B., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.170428 · Cited by 46 · see citing works

Dietary (poly)phenols mitigate inflammatory bowel disease: Therapeutic targets, mechanisms of action, and clinical observations

Jamieson, P. E., Carbonero, F. G., & Stevens, J. F. (2023) · Current Research in Food Science · doi:10.1016/j.crfs.2023.100521 · Cited by 43 · see citing works

The role of cholesterol and mitochondrial bioenergetics in activation of the inflammasome in IBD

Astorga, J., Gasaly, N., Dubois‐Camacho, K., la Fuente, M. D., Landskron, G., Faber, K. N., Urra, F. A., & Hermoso, M. A. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1028953 · Cited by 41 · see citing works

Bile Acid Malabsorption Deactivates Pregnane X Receptor in Patients with Crohn’s Disease

Iwamoto, J., Saito, Y., Honda, A., Miyazaki, T., Ikegami, T., & Matsuzaki, Y. (2013) · Inflammatory Bowel Diseases · doi:10.1097/mib.0b013e318281f423 · Cited by 40 · see citing works

Activation of FXR modulates SOCS3/Jak2/STAT3 signaling axis in a NASH-dependent hepatocellular carcinoma animal model

Attia, Y. M., Tawfiq, R. A., Gibriel, A. A., Ali, A. A., Kassem, D. H., Hammam, O. A., & Elmazar, M. M. (2021) · Biochemical Pharmacology · doi:10.1016/j.bcp.2021.114497 · Cited by 39 · see citing works

The Role of Gut Microbiota in Gastrointestinal Immune Homeostasis and Inflammation: Implications for Inflammatory Bowel Disease

Bretto, E., Caviglia, G. P., Saracco, G. M., Bugianesi, E., & Ribaldone, D. G. (2025) · Biomedicines · doi:10.3390/biomedicines13081807 · Cited by 38 · see citing works

The farnesoid-X-receptor in myeloid cells controls CNS autoimmunity in an IL-10-dependent fashion

Hucke, S., Herold, M. V. B., Liebmann, M., Freise, N., Lindner, M., Fleck, A.-K., Zenker, S., Thiebes, S., Fernández‐Orth, J., Buck, D., et al. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1593-6 · Cited by 38 · see citing works

Anthranilic acid derivatives as novel ligands for farnesoid X receptor (FXR)

Merk, D., Gabler, M., Gomez, R. C., Flesch, D., Hanke, T., Kaiser, A., Lamers, C., Werz, O., Schneider, G., & Schubert‐Zsilavecz, M. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.02.053 · Cited by 35 · see citing works

Bacterial metabolites directly modulate farnesoid X receptor activity

Zhang, X., Osaka, T., & Tsuneda, S. (2015) · Nutrition & Metabolism · doi:10.1186/s12986-015-0045-y · Cited by 34 · see citing works

Diarrhea in Crohn’s Disease: Investigating the Role of the Ileal Hormone Fibroblast Growth Factor 19

Nolan, J., Johnston, I. M., Pattni, S. S., Dew, T. K., Orchard, T. R., & Walters, J. R. F. (2014) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jju022 · Cited by 34 · see citing works

Systems Biology Approaches for Inflammatory Bowel Disease

Moco, S., Candela, M., Chuang, E., Draper, C. F., Cominetti, O., Montoliu, I., Barron, D., Kussmann, M., Brigidi, P., Gionchetti, P., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000116 · Cited by 32 · see citing works

Potential of Intestine-Selective FXR Modulation for Treatment of Metabolic Disease

van Zutphen, T., Bertolini, A., de Vries, H. D., Bloks, V. W., de Boer, J. F., Jonker, J. W., & Kuipers, F. (2019) · Handbook of experimental pharmacology · doi:10.1007/164_2019_233 · Cited by 30 · see citing works

Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease

Valentino, P. L., Feldman, B. M., Walters, T. D., Griffiths, A. M., Ling, S. C., Pullenayegum, E., & Kamath, B. M. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000558 · Cited by 29 · see citing works

Gut Microbiota, Peroxisome Proliferator-Activated Receptors, and Hepatocellular Carcinoma

Yu, Q., Wu, L., Ji, J., Feng, J., Dai, W., Li, J., Wu, J., & Guo, C. (2020) · Journal of Hepatocellular Carcinoma · doi:10.2147/jhc.s277870 · Cited by 27 · see citing works

Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease

Ning, L., Lou, X., Zhang, F., & Xu, G. (2019) · Mediators of Inflammation · doi:10.1155/2019/2624941 · Cited by 27 · see citing works

Alterations in Enterohepatic Fgf15 Signaling and Changes in Bile Acid Composition Depend on Localization of Murine Intestinal Inflammation

Rau, M., Stieger, B., Monte, M. J., Schmitt, J., Jahn, D., Frey-Wagner, I. M., Raselli, T., Marı́n, J. J. G., Müllhaupt, B., Rogler, G., et al. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000879 · Cited by 26 · see citing works

Crohn’s Disease Is Associated with Decreased CYP3A4 and P‑Glycoprotein Protein Expression

Wilson, A. S., Urquhart, B. L., Ponich, T. P., Chande, N., Gregor, J. C., Beaton, M. D., & Kim, R. B. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.9b00459 · Cited by 26 · see citing works

Sanhuang xiexin decoction ameliorates secondary liver injury in DSS-induced colitis involve regulating inflammation and bile acid metabolism

Li, L., Wang, Y., Zhao, L., Ye, G., Shi, F., Li, Y., Zou, Y., Song, X., Zhao, X., Yin, Z., et al. (2022) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2022.115682 · Cited by 25 · see citing works

Pharmacological Activation of the Bile Acid Nuclear Farnesoid X Receptor Is Feasible in Patients with Quiescent Crohn's Colitis

van Schaik, F. D. M., Gadaleta, R. M., Schaap, F. G., van Mil, S. W. C., Siersema, P. D., Oldenburg, B., & van Erpecum, K. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0049706 · Cited by 25 · see citing works

Farnesoid x receptor in human metabolism and disease: the interplay between gene polymorphisms, clinical phenotypes and disease susceptibility

Koutsounas, I. S., Theocharis, S. E., Delladetsima, I. K., Patsouris, E., & Giaginis, C. (2015) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2014.999664 · Cited by 25 · see citing works

The cell biology of the intestinal epithelium and its relation to inflammatory bowel disease

Deuring, J. J., de Haar, C. G., Kuipers, E. J., Peppelenbosch, M. P., & van der Woude, C. J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2012.12.020 · Cited by 23 · see citing works

Altered enterohepatic circulation of bile acids in Crohn’s disease and their clinical significance: a new perspective

Nolan, J., Johnston, I. M., & Walters, J. R. F. (2012) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/egh.12.66 · Cited by 23 · see citing works

Hepatoprotective effect of bisbenzylisoquinoline alkaloid tiliamosine from Tiliacora racemosa in high-fat diet/diethylnitrosamine-induced non-alcoholic steatohepatitis

Darvin, S. S., Toppo, E., Esakkimuthu, S., Krishna, T. P. A., Ceasar, S. A., Stalin, A., Balakrishna, K., Muniappan, N., Pazhanivel, N., Mahaprabhu, R., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.09.116 · Cited by 22 · see citing works

Intestinal failure to produce FGF19: A culprit in intestinal failure–associated liver disease?

van Erpecum, K. J., & Schaap, F. G. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.012 · Cited by 22 · see citing works

Bile Acids and the Microbiome: Making Sense of This Dynamic Relationship in Their Role and Management in Crohn’s Disease

Kumar, A., Al-Hassi, H. O., Steed, H., Phipps, O., & Brookes, M. (2022) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2022/8416578 · Cited by 21 · see citing works

Structural Investigation for Optimization of Anthranilic Acid Derivatives as Partial FXR Agonists by in Silico Approaches

Chen, M., Yang, X., Lai, X., Kang, J., Gan, H., & Gao, Y. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17040536 · Cited by 20 · see citing works

Therapeutic Role of Bile Acids and Nuclear Receptor Agonists in Fibrosing Cholangiopathies

Trauner, M., Halilbasic, E., Kazemi-Shirazi, L., Kienbacher, C., Staufer, K., Traussnigg, S., & Hofer, H. (2014) · Digestive Diseases · doi:10.1159/000360517 · Cited by 19 · see citing works

Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties

Flesch, D., Gabler, M., Lill, A., Gomez, R. C., Steri, R., Schneider, G., Stark, H., Schubert‐Zsilavecz, M., & Merk, D. (2015) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2015.04.035 · Cited by 19 · see citing works

Farnesoid X Receptor in Mice Prevents Severe Liver Immunopathology During Lymphocytic Choriomeningitis Virus Infection

Honke, N., Shaabani, N., Hardt, C., Krings, C., Häussinger, D., Lang, P. A., Lang, K. S., & Keitel, V. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000456168 · Cited by 18 · see citing works

Impact of Global Fxr Deficiency on Experimental Acute Pancreatitis and Genetic Variation in the FXR Locus in Human Acute Pancreatitis

Nijmeijer, R. M., Schaap, F. G., Smits, A. J. J., Kremer, A. E., Akkermans, L. M. A., Kroese, A. B. A., Rijkers, G. T., Schipper, M. E. I., Verheem, A., Wijmenga, C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0114393 · Cited by 17 · see citing works

Characterizing ligands for farnesoid X receptor – availablein vitrotest systems for farnesoid X receptor modulator development

Merk, D., Steinhilber, D., & Schubert‐Zsilavecz, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2014.860129 · Cited by 16 · see citing works

Farnesoid X Receptor Expression in Microscopic Colitis: A Potential Role in Disease Etiopathogenesis

Torres, J., Palmela, C., de Sena, P. G., Santos, M. P. C., Gouveia, C. F., Oliveira, M. H., Henriques, A. R., Rodrigues, C. M. P., Cravo, M. L., & Borralho, P. (2017) · GE Portuguese Journal of Gastroenterology · doi:10.1159/000481197 · Cited by 16 · see citing works

Differential roles of farnesoid X receptor (FXR) in modulating apoptosis in cancer cells

Girisa, S., Rana, V., Parama, D., Dutta, U., & Kunnumakkara, A. B. (2021) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2021.02.006 · Cited by 15 · see citing works

Sex differences feed into nuclear receptor signaling along the digestive tract

Dean, A. E., Reichardt, F., & Anakk, S. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2021.166211 · Cited by 14 · see citing works

Genetic variation in the farnesoid X-receptor predicts Crohn’s disease severity in female patients

Wilson, A. S., Wang, Q., Almousa, A. A., Jansen, L. E., Choi, Y., Schwarz, U. I., & Kim, R. B. (2020) · Scientific Reports · doi:10.1038/s41598-020-68686-9 · Cited by 14 · see citing works

Polypropylene microplastics triggered mouse kidney lipidome reprogramming combined with ROS stress as revealed by lipidomics and Raman biospectra

Liu, M., Wang, M., Sun, X., Mu, J., Teng, T., Jin, N., Song, J., Li, B., & Zhang, D. (2024) · Chemosphere · doi:10.1016/j.chemosphere.2024.143926 · Cited by 12 · see citing works

Review article: insights into the bile acid‐gut microbiota axis in intestinal failure‐associated liver disease—redefining the treatment approach

Wang, Y., Zheng, L., Zhou, Z., Yao, D., Huang, Y., Liu, B., Duan, Y., & Li, Y. (2021) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16676 · Cited by 12 · see citing works

An Inverse Correlation of Serum Fibroblast Growth Factor 19 with Abdominal Pain and Inflammatory Markers in Patients with Ulcerative Colitis

Panek-Jeziorna, M., & Mulak, A. (2020) · Gastroenterology Research and Practice · doi:10.1155/2020/2389312 · Cited by 11 · see citing works

Serum Levels of Fibroblast Growth Factor 19 Correlate with the Severity of Diarrhea and Independently from Intestinal Inflammation in Patients with Inflammatory Bowel Disease or Microscopic Colitis

Lyutakov, I., Nakov, R., Valkov, H. Y., Vatcheva-Dobrevska, R., Vladimirov, B. G., & Penchev, P. I. (2021) · The Turkish Journal of Gastroenterology · doi:10.5152/tjg.2021.20247 · Cited by 11 · see citing works

The Gdac1 locus modifies spontaneous and Salmonella-induced colitis in mice deficient in either Gpx2 or Gpx1 gene

Esworthy, R. S., Kim, B.-W., Wang, Y., Gao, Q., Doroshow, J. H., Leto, T. L., & Chu, F. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.09.013 · Cited by 10 · see citing works

Bile Acids in Control of the Gut-Liver-Axis

Hild, B., Heinzow, H. S., Schmidt, H., & Maschmeier, M. (2021) · Zeitschrift für Gastroenterologie · doi:10.1055/a-1330-9644 · Cited by 10 · see citing works

Ten Reasons to Think About Bile Acids in Managing Inflammatory Bowel Disease

Camilleri, M. (2020) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjaa175 · Cited by 9 · see citing works

Discovery and Optimization of Novel Nonbile Acid FXR Agonists as Preclinical Candidates for the Treatment of Inflammatory Bowel Disease

Li, Y., Xu, T., Zhao, Y., Zhang, H., Liu, Z., Wang, H., Huang, C.-Y., Shu, Z., Gao, L., Xie, R., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02304 · Cited by 9 · see citing works

Activation of Farnesoid X Receptor Increases the Expression of Cytokine Inducible SH2-Containing Protein in HepG2 Cells

Xu, Z., Huang, G., Gong, W., Zhao, Y., Zhou, P., Zeng, Y., & He, F. (2012) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2012.0008 · Cited by 8 · see citing works

Design, Synthesis, and Biological Evaluation of New Ureido (Thioureido) Anthranilic Acid Isosteres: Molecular Docking, In Silico ADMET Predictions, and In Vivo Anti‐Inflammatory Activity

Harrouche, K., Boutaoui, N., Saidi, K. M., Stiti, M. Z., Khellafi, A., & Khelili, S. (2025) · Chemistry & Biodiversity · doi:10.1002/cbdv.202500374 · Cited by 7 · see citing works

Intestinal Farnesoid X Receptor Modulates Duodenal Surface Area but Does Not Control Glucose Absorption in Mice

Yang, J., van Dijk, T. H., Koehorst, M., Havinga, R., de Boer, J. F., Kuipers, F., & van Zutphen, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044132 · Cited by 7 · see citing works

Bariatric surgery attenuates colitis in an obese murine model

Li, S., Vinci, A., Behnsen, J., Cheng, C., Jellbauer, S., Raffatellu, M., Sousa, K. M., Edwards, R. A., Nguyen, N. T., Stamos, M. J., et al. (2016) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2016.10.024 · Cited by 6 · see citing works

Xenobiotic and endobiotic handling by the mucosal immune system

Chen, M. L., & Sundrud, M. S. (2018) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000478 · Cited by 6 · see citing works

Farnesoid X receptor activation alleviates hepatic encephalopathy by improving hepatic ammonia metabolism in murine models

Ye, W., Bai, X., Zhao, Y., Du, Z., Liu, F., Wang, Y., & Chen, W. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.167750 · Cited by 5 · see citing works

SU5, a new Auraptene analog with improved metabolic stability, ameliorates nonalcoholic fatty liver disease in methionine‐ and choline‐deficient diet‐fed db/db mice

Wen, F., Bian, D., Wu, X., Liu, R., Wang, C., & Gan, J. (2022) · Chemical Biology & Drug Design · doi:10.1111/cbdd.14021 · Cited by 5 · see citing works

Reversing metabolic dysregulation in farnesoid X receptor knockout mice via gut microbiota modulation

Paraiso, I. L., Magaña, A. A., Alexiev, A., Sharpton, T. J., Maier, C. S., Kioussi, C., & Stevens, J. F. (2025) · PLoS ONE · doi:10.1371/journal.pone.0331040 · Cited by 4 · see citing works

The expanding role of the bile acid receptor farnesoid X in the intestine and its potential clinical implications

Ceulemans, L. J., Canovai, E., Verbeke, L., Pirenne, J., & Farré, R. (2016) · Acta chirurgica Belgica · doi:10.1080/00015458.2016.1215953 · Cited by 4 · see citing works

Nuclear Receptors and Lipid Sensing

Thorne, J. L., & Cioccoloni, G. (2022) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-11836-4_5 · Cited by 3 · see citing works

Role of Bile Acids and Nuclear Receptors in Acupuncture in Improving Crohn’s Disease

Shen, J., Qi, Q., Han, D., Liu, S., Huang, R., Zhu, Y., Zheng, H., Gu, K., Wu, H., & Liu, H. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/5814048 · Cited by 3 · see citing works

Relationship between NR1I2 polymorphisms and inflammatory bowel disease risk: A systematic review and meta-analysis

Sun, M.-Y., & Lin, J. (2016) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2016.10.006 · Cited by 2 · see citing works

Nuclear receptors as therapeutic targets in metabolic and cardiovascular disorders

Li, F., Chen, Q., Dai, Y., & Lu, L. (2025) · iScience · doi:10.1016/j.isci.2025.114042 · Cited by 1 · see citing works

Duodenal mucosal RNA-Seq identifies coordinated bile acid–axis transcriptional alterations in food-responsive enteropathy in dogs

Mózes, B., Kiss, G., Fóthi, Á., Ferenczi, S., & Psáder, R. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1829399 · Cited by 1 · see citing works

Genetic Predictors of Cytomegalovirus Infection in Patients With Inflammatory Bowel Disease

Nguyen, M. H. N., Bradford, K., Huang, B. L., Haritunians, T., Fleshner, P., Himmelfarb, E. A., Landers, C. J., Vasiliauskas, E. A., Ippoliti, A., MELMED, G. Y., et al. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)61091-3

A Functional Variant of the Farnesoid X Receptor (FXR) Predisposes to Ileocolonic Localization of Crohn's Disease

Nijmeijer, R. M., Gadaleta, R. M., van Erpecum, K. J., Bodegraven, A. A. V., Crusius, J. B. A., Dijkstra, G. D. H., Hommes, D. W., de Jong, D. J., Ponsioen, C. Y., Verspaget, H. W., et al. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)61088-3

Analysis of CEACAM6 Gene Variants in Inflammatory Bowel Disease

Diegelmann, J., Glas, J., Fries, C., Göke, B., Czamara, D., & Brand, S. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)61090-1

Dissection of the Crohn's Disease Transcriptome of 71 Loci Using Genome-Wide Microarrays

Palmieri, O., Latiano, A., Maglietta, R., Palumbo, O., Corritore, G., Latiano, T., Martino, G., Carella, M., Ancona, N., Bossa, F., et al. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)61092-5

Identification of Novel DMBT1 Gene Variants as Susceptibility Variants for Crohn's Disease and Ulcerative Colitis

Diegelmann, J., Bras, E. L., Göke, B., Czamara, D., Glas, J., & Brand, S. (2011) · Gastroenterology · doi:10.1016/s0016-5085(11)61089-5